- The Impact of COVID-19 Regulations on Adherence to Recombinant Human Growth Hormone Therapy: Evidence from Real-World Data
- Use of machine learning to identify patients at risk of sub‑optimal adherence: study based on real‑world data from 10,929 children using a connected auto‑injector device
- A Machine Learning Approach for Identifying Children at Risk of Suboptimal Adherence to Growth Hormone Therapy
- A Data-Driven Intervention Framework for Improving Adherence to Growth Hormone Therapy Based on Clustering Analysis and Traffic Light Alerting Systems